LEIDOS BIOMEDICAL RESEARCH, INC. holds $2.3B across 187 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 4 related awards under parent 75N91019D00024. Competition previously drew 2 offers. Recompete timing centers on the Sep 29, 2026 PoP end — agencies typically plan 12–18 months ahead.
THIS COVID TASK ORDER SUPPORTS NIAIDS NEED TO CONDUCT A TRIAL OF AN ADDITIONAL DOSE VACCINE TO EVALUATE VARIANT VACCINES ALONE OR IN COMBINATION IN AN IMMUNOLOGICALLY DIVERSE POPULATION. THE WORK INCLUDES THE ABILITY TO PROVIDE THE MANAGEMENT, OVERS
Current PoP ends Sep 29, 2026 (64 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.
Track recompete timing in SCOUT →LEIDOS BIOMEDICAL RESEARCH, INC. — $2.3B obligated across 187 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Live Demand-Fit + Displacement scoring, alerts on verdict flips, and watchlists. Free — no card required.
See all live recompete landscapes — who else is expiring, and where the openings are.
Open LEIDOS BIOMEDICAL RESEARCH, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Register free to start exploring SCOUT →